STEPHENSON BRIAN C 4
4 · BridgeBio Pharma, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
STEPHENSON BRIAN C
Secretary, Treasurer & CFO
Transactions
- Sale
Common Stock
2024-11-19$22.41/sh−4,156$93,137→ 93,758 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 22, 2024.
- [F2]Represents the weighted average sale price of the shares sold ranging from $21.95 to $22.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.